REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)

NCT07302451 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer (Adenocarcinoma)

Interventions

COMBINATION_PRODUCT: Combined Androgen Deprivation Therapy with Relugolix and Image-Guided Stereotactic Body Radiotherapy (SBRT)

Sponsor

National Cancer Institute, Naples